Global Diabetes Nutrition Market: Restraint
Increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration is expected to hinder the market growth. For instance, in November 2020, the U.S. Food and Drug Administration recalled metformin hydrochrolide, a medication for glucose management in patients with type 2 diabetes which was manufactured by Marksans Pharma, a pharmaceutical company. The drug was recalled due the detection of high levels of N-nitrosodimethylamine, an organic compound linked to causing cancer in high concentrations.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients